Gritstone bio Inc. (NASDAQ: GRTS) Stock Information | RedChip

Gritstone bio Inc. (NASDAQ: GRTS)


$0.70
-0.0094 ( -1.32% ) 53.8K

Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Market Data


Open


$0.70

Previous close


$0.71

Volume


53.8K

Market cap


$76.43M

Day range


$0.68 - $0.71

52 week range


$0.52 - $3.33

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 26, 2024
8-k 8K-related 13 Jun 25, 2024
8-k 8K-related 13 Jun 24, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 May 17, 2024

Latest News